106 related articles for article (PubMed ID: 15492244)
1. Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish.
Yang HW; Kutok JL; Lee NH; Piao HY; Fletcher CD; Kanki JP; Look AT
Cancer Res; 2004 Oct; 64(20):7256-62. PubMed ID: 15492244
[TBL] [Abstract][Full Text] [Related]
2. Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.
Fielitz K; Althoff K; De Preter K; Nonnekens J; Ohli J; Elges S; Hartmann W; Klöppel G; Knösel T; Schulte M; Klein-Hitpass L; Beisser D; Reis H; Eyking A; Cario E; Schulte JH; Schramm A; Schüller U
Oncotarget; 2016 Nov; 7(46):74415-74426. PubMed ID: 27769070
[TBL] [Abstract][Full Text] [Related]
3. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
[TBL] [Abstract][Full Text] [Related]
4. Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system.
Liu S; Leach SD
Methods Cell Biol; 2011; 105():367-81. PubMed ID: 21951538
[TBL] [Abstract][Full Text] [Related]
5. ff1b, the SF1 ortholog, is important for pancreatic islet cell development in zebrafish.
Mazilu JK; Powers JW; Lin S; McCabe ER
Mol Genet Metab; 2010 Dec; 101(4):391-4. PubMed ID: 20965759
[TBL] [Abstract][Full Text] [Related]
6. Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma.
Gupta A; Williams BR; Hanash SM; Rawwas J
Cancer Res; 2006 Aug; 66(16):8100-8. PubMed ID: 16912187
[TBL] [Abstract][Full Text] [Related]
7. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
8. Generation of living color transgenic zebrafish to trace somatostatin-expressing cells and endocrine pancreas organization.
Li Z; Wen C; Peng J; Korzh V; Gong Z
Differentiation; 2009 Feb; 77(2):128-34. PubMed ID: 19281772
[TBL] [Abstract][Full Text] [Related]
9. Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvatecarboxykinase-SV40 T antigen transgenic rats.
Haas MJ; Sattler CA; Dragan YP; Gast WL; Pitot HC
Pancreas; 2000 Mar; 20(2):206-14. PubMed ID: 10707938
[TBL] [Abstract][Full Text] [Related]
10. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression.
Rindi G; Grant SG; Yiangou Y; Ghatei MA; Bloom SR; Bautch VL; Solcia E; Polak JM
Am J Pathol; 1990 Jun; 136(6):1349-63. PubMed ID: 2162628
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.
Alaminos M; Mora J; Cheung NK; Smith A; Qin J; Chen L; Gerald WL
Cancer Res; 2003 Aug; 63(15):4538-46. PubMed ID: 12907629
[TBL] [Abstract][Full Text] [Related]
12. Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions.
Koma Y; Furuno T; Hagiyama M; Hamaguchi K; Nakanishi M; Masuda M; Hirota S; Yokozaki H; Ito A
Gastroenterology; 2008 May; 134(5):1544-54. PubMed ID: 18471525
[TBL] [Abstract][Full Text] [Related]
13. Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma.
Cheng AJ; Cheng NC; Ford J; Smith J; Murray JE; Flemming C; Lastowska M; Jackson MS; Hackett CS; Weiss WA; Marshall GM; Kees UR; Norris MD; Haber M
Eur J Cancer; 2007 Jun; 43(9):1467-75. PubMed ID: 17449239
[TBL] [Abstract][Full Text] [Related]
14. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.
Woo CW; Tan F; Cassano H; Lee J; Lee KC; Thiele CJ
Pediatr Blood Cancer; 2008 Feb; 50(2):208-12. PubMed ID: 17420990
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma.
Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB
Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic endocrine tumors with ductules.
Chetty R; Asa SL; Adsay NV
Am J Surg Pathol; 2005 Jan; 29(1):136-7; author reply 137-8. PubMed ID: 15613869
[No Abstract] [Full Text] [Related]
17. Rapamycin inhibits proliferation of human neuroblastoma cells without suppression of MycN.
Misawa A; Hosoi H; Tsuchiya K; Sugimoto T
Int J Cancer; 2003 Mar; 104(2):233-7. PubMed ID: 12569580
[TBL] [Abstract][Full Text] [Related]
18. [The establishment of a human pancreatic mixed ductal-endocrine carcinoma cell line].
Hou M; Gao J; Liu T; Cui Q
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):422-6. PubMed ID: 11869555
[TBL] [Abstract][Full Text] [Related]
19. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.
Song L; Ara T; Wu HW; Woo CW; Reynolds CP; Seeger RC; DeClerck YA; Thiele CJ; Sposto R; Metelitsa LS
J Clin Invest; 2007 Sep; 117(9):2702-12. PubMed ID: 17710228
[TBL] [Abstract][Full Text] [Related]
20. Targeted expression of MYCN causes neuroblastoma in transgenic mice.
Weiss WA; Aldape K; Mohapatra G; Feuerstein BG; Bishop JM
EMBO J; 1997 Jun; 16(11):2985-95. PubMed ID: 9214616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
